Praxis Precision Medicines

Company snapshot

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance. Praxis is applying insights into the genetic mutations that drive excitation-inhibition imbalance in diseases to select biological targets for rare and more prevalent neurological disorders.

• 1 approved product(s) across US/EU regulatory metadata.
• 7 active pipeline program(s) linked via ClinicalTrials.gov.
• 35 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Praxis Precision Medicines. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Praxis Precision Medicines.

1. Jun 8, 2026 Clinical update

   2021-02508 — Unknown

2. Jun 8, 2026 Clinical update

   PRX-P4-003, (-)-FCF — Phase 1

3. Jun 5, 2026 Clinical update

   Pneumococcal Vaccine, Polyvalent (23-valent) — Phase 1

4. Jun 5, 2026 Clinical update

   Nimotuzumab — Phase 3

5. Jun 5, 2026 Clinical update

   HIV-1 C4-V3 Polyvalent Peptide Vaccine — Phase 1

View all clinical trial activity →

• What is Praxis Precision Medicines?

  Praxis Precision Medicines is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker PRAX. Primary therapeutic focus areas include HIV Infections, Major Depressive Disorder, Pancreatic Cancer, Advanced or Metastatic, Telemedicine, Spinal Cord Injury Ce

• Is Praxis Precision Medicines publicly traded?

  Yes. Praxis Precision Medicines is listed with ticker PRAX on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Praxis Precision Medicines develop or market?

  We link 8 drug profile(s) where Praxis Precision Medicines is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/praxis-precision-medicines#company-drugs.

• What are the latest developments for Praxis Precision Medicines?

  In the last 12 months our linked public records show 7 trial program update(s) and 2 US patent grant(s) tied to this profile.

• What therapeutic areas does Praxis Precision Medicines focus on?

  Praxis Precision Medicines focuses on HIV Infections, Major Depressive Disorder, Pancreatic Cancer, Advanced or Metastatic based on our analysis of their pipeline programs and drug development activities.